Report: New blood test for early detection of 8 major cancer types What does this mean for you? You may have heard the recent hype about a new study in which a blood test was used for the early detection of 8 major cancer types. What does the study really mean and, more importantly, when […]
Free event to foster collaboration between scientists SEATTLE – Dec 1, 2017 – The Rivkin Center for Ovarian Cancer is proud to present the 1st biennial Northwest Gynecological Cancer Symposium (NGCS) to be held on Monday, December 4th, 2017 from 8am – 7pm at Pelton Auditorium at Fred Hutch in Seattle. NGCS is designed to […]
Dr. Rivkin and I attended the annual meeting of the American Society of Clinical Oncology (ASCO)—a gathering of 38,000 oncology experts from all over the world—in early June in Chicago, Illinois. In addition to oncologists, the attendees included researchers, educators, advocates, research funders, survivors and representatives from genetic testing, drug and other services companies. Our […]
A study published in Lancet Oncology by Dr. Iain McNeish (2016 Rivkin Pilot Award Recipient), Dr. Elizabeth Swisher (2009 Rivkin Pilot Award Recipient), and colleagues provided key data that helped fuel the FDA’s recent approval of rucaparib for ovarian cancers with defects in the BRCA1 and BRCA2 genes in women previously treated with two or more chemotherapies.
The Courage for Life Award was named in honor of Joe and Tyler White’s commitment to the Rivkin Center and the loving memory of Lori White and Mary Ellen Bissell, and recognizes those who, in the face of ovarian cancer, demonstrate a profound passion for life, a generosity to others, and an important contribution to […]
Long-term Rivkin Center partner, Skacel Collection, Inc. is launching a special promotion this September through their Makers Mercantile site! In honor of Ovarian Cancer Awareness Month and inspired by the Skacel family’s commitment to supporting ovarian cancer research, the company is offering a 10% discount off your ENTIRE purchase, which results in a 10% donation […]
Guest blogger Carol Reed shares the story of when she was diagnosed with ovarian cancer. Each woman’s ovarian cancer story is unique, and Carol emphasizes that she speaks only for herself. This is her experience.
Our 2016 SummeRun honoree has supported the event in almost every way possible—a survivor, a team captain, a fundraiser, and one of the top survivor finishers in last year’s run.
Jim Harting left the Rivkin Center the proceeds of the sale of his farm, and the $536,000 gift that Rivkin received this spring as a result of this bequest became one of the largest single gifts in our organization’s history.